CORTICOSTEROID INJECTIONS VERSUS PROLOTHERAPY FOR THE TREATMENT OF LATERAL EPICONDYLITIS: A RANDOMISED-CONTROLLED TRIAL

被引:0
作者
Pal, Utkarsh [1 ]
Kiradiya, Nitin [1 ]
机构
[1] Bundelkhand Med Coll, Dept Orthopaed, Sagar, Madhya Pradesh, India
来源
JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS | 2016年 / 5卷 / 72期
关键词
Prolotherapy; Lateral Epicondylitis; Injection Therapy; Tendinopathy;
D O I
10.14260/jemds/2016/1199
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To compare the efficacy of corticosteroid injection versus prolotherapy for the treatment of chronic lateral epicondylitis. DESIGN A prospective, randomised-controlled study. PARTICIPANTS Thirty-six subjects with clinically determined chronic ( of duration three months or longer) lateral epicondylitis were recruited. All subjects noted pain intensity levels disturbing enough to prevent involvement in activities such as kneading dough, wringing clothes, lifting heavy weights and playing racquet sports. METHODS Subjects were randomised to get either corticosteroid injection or prolotherapy for treatment of chronic lateral epicondylitis. Each subject underwent injection at baseline followed by a second injection 3 weeks later. RESULTS Analysis in both the groups demonstrated statistically significant improvements in VAS and DASH scores within the prolotherapy group having significant changes recorded from baseline to 2 months and baseline to 6 months after initial treatment. The steroid group also recorded a clinically and statistically significant change for DASH only at both 2 month and 6 month followup. Analysis and comparison of the subjects completing the study gave no significant differences between the prolotherapy and the corticosteroid group for change in VAS or DASH, although at 1 year followup, 2 patients out of 20 patients reported sometimes pain in corticosteroid group while nobody reported pain in prolotherapy group. The study lacked sufficient power to draw conclusions from this finding. Aside from injection-associated pain, no other adverse reactions were documented. CONCLUSIONS Both corticosteroid and prolotherapy therapy were generally well tolerated and showed to provide benefit of short duration, however, prolotherapy gets preference on long term. Small sample size precludes determining whether one therapy is advantageous to the other. Larger controlled trials appear feasible and justified on the basis of these findings.
引用
收藏
页码:5292 / 5295
页数:4
相关论文
共 20 条
  • [1] Sclerosing injections to areas of neo-vascularisation reduce pain in chronic Achilles tendinopathy:: a double-blind randomised controlled trial
    Alfredson, H
    Öhberg, L
    [J]. KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2005, 13 (04) : 338 - 344
  • [2] Suture plication, thermal shrinkage, and sclerosing agents - Effects on rat patellar tendon length and biomechanical strength
    Aneja, A
    Karas, SG
    Weinhold, PS
    Afshari, HM
    Dahners, LE
    [J]. AMERICAN JOURNAL OF SPORTS MEDICINE, 2005, 33 (11) : 1729 - 1734
  • [3] Banks A, 1991, J ORTHOP MED, V13, P54
  • [4] Varicose veins: Newer, better treatments available
    Bartholomew, JR
    King, T
    Sahgal, A
    Vidimos, AT
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2005, 72 (04) : 312 - +
  • [5] Beaton D E, 2001, J Hand Ther, V14, P128
  • [6] Prolotherapy Versus Corticosteroid Injections for the Treatment of Lateral Epicondylosis: A Randomized Controlled Trial
    Carayannopoulos, Alexios
    Borg-Stein, Joanne
    Sokolof, Jonas
    Meleger, Alec
    Rosenberg, Darren
    [J]. PM&R, 2011, 3 (08) : 706 - 715
  • [7] Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
    Farrar, JT
    Young, JP
    LaMoreaux, L
    Werth, JL
    Poole, RM
    [J]. PAIN, 2001, 94 (02) : 149 - 158
  • [8] Hackett G.S., 1993, LIGAMENT TENDON RELA
  • [9] HAMILTON PG, 1986, J ROY COLL GEN PRACT, V36, P464
  • [10] HASLOCK I, 1995, BRIT J RHEUMATOL, V34, P449